Melasma - Melazma
https://en.wikipedia.org/wiki/Melasma
☆ Germaniyaning 2022 yilgi Stiftung Warentest natijalariga ko'ra, iste'molchilarning ModelDermdan qoniqish darajasi pullik teletibbiyot maslahatlariga qaraganda bir oz pastroq bo'lgan. 

Bu 40 yoshdan oshgan osiyolik ayollarda kuzatiladigan keng tarqalgan holat. Suratdagi doira shaklidagi lezyon melazma emas, balki lentigoga yaqinroq.
relevance score : -100.0%
References
Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review 28374042Tranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. This systematic review searched major databases for relevant publications to March 2016. Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma Area and Severity Index (MASI) showed a decrease of 1.60 in MASI after treat?ment with tranexamic acid. The addition of tranexamic acid to routine treatment modalities resulted in a further decrease in MASI of 0.94. These results support the efficacy and safety of tranexamic acid, either alone or as an adjuvant to routine treatment modalities for melasma.
The Low-Fluence Q-Switched Nd:YAG Laser Treatment for Melasma: A Systematic Review 35888655 NIH
So'nggi paytlarda low-fluence Q-switched Nd:YAG (LFQSNY) lazer melazmani davolashda, ayniqsa Osiyoda mashhur bo'ldi. Turli tadqiqotlarni sarhisob qilish qiyin edi, ammo LFQSNY an'anaviy davolash usullariga qaraganda melazma uchun odatda samarali va xavfsiz ko'rinadi. Shu bilan birga, ba'zi dog'li gipopigmentatsiya holatlari LFQSNY ning yon ta'siri sifatida, ehtimol, yuqori lazer energiyasi tufayli xabar qilingan. LFQSNY dan tajovuzkor foydalanish, shuningdek, yallig'lanish natijasida giperpigmentatsiyaga olib kelishi mumkin, ayniqsa qoraygan teri ohanglarida.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Pigmentation Disorders: Diagnosis and Management 29431372Pigmentatsiya muammolari ko'pincha birlamchi tibbiy yordamda topiladi. Giperpigmentatsiya kasalliklarining keng tarqalgan turlari post-inflammatory hyperpigmentation, melasma, sunspots, freckles, and café au lait spots ni o'z ichiga oladi.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Melazmani ma'lum vaqt davomida lazer bilan davolash bilan bartaraf etib bo'lmaydi, chunki bu pigment doimiy ravishda ishlab chiqariladigan kasallikdir. Tranksemik kislota pigmentatsiyani kamaytirishga yordam beradi.
○ Davolash
Ba'zi mamlakatlarda (masalan, Yaponiya, Koreya) og'iz orqali traneksamik kislota retseptsiz mavjud va samarali. Traneksamik kislota va azelaik kislota bilan melazma kremi qisman foydali bo'lishi mumkin.
Gidrokinon giperpigmentatsiyani davolash uchun mahalliy sifatida ishlatilishi mumkin, ammo FDA 2020 yildan boshlab gidroxinonni o'z ichiga olgan OTC mahsulotlarini to'xtatdi.
#Tranexamic acid [TRANSINO]
#Laser toning technique (low fluence QS1064 laser)
#Triluma